GSK3B and malaria: In contrast, the inhibition of GSK-3β by DBP increases the GSK-3β Ser9 phosphorylation level in the liver of male, six-week-old ICR mice infected with Plasmodium berghei, by which DBP was implicated as a potential malaria treatment in vivo [14].